Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,079,586 | -221,315 | -614,928 | -78,782 | -88,602 |
| Depreciation Amortization | 146 | 89 | 198 | 2,514 | 2,455 |
| Accounts receivable | N/A | N/A | 359 | 975 | -1,138 |
| Accounts payable and accrued liabilities | 15,303 | 2,015 | 2,263 | -4,132 | -1,711 |
| Other Working Capital | 31,416 | 15,479 | -4,684 | 179 | 5,948 |
| Other Operating Activity | 709,791 | 61,626 | 540,032 | 37,664 | 10,461 |
| Operating Cash Flow | $-322,930 | $-142,106 | $-76,760 | $-41,582 | $-72,587 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -173,653 | -190,195 | -112,857 | N/A | N/A |
| PPE Investments | -657 | -139 | 98 | -624 | -306 |
| Other Investing Activity | 0 | -15,007 | -475,015 | 0 | 0 |
| Investing Cash Flow | $-174,310 | $-205,341 | $-587,774 | $-624 | $-306 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 545,000 | 110,000 |
| Common Stock Issued | 617,533 | 481,227 | 110,615 | 100,399 | 78,088 |
| Other Financing Activity | 0 | -100,000 | -24,102 | -25,155 | -110,172 |
| Financing Cash Flow | $617,533 | $381,227 | $86,513 | $620,244 | $77,916 |
| Exchange Rate Effect | 102 | -18 | 839 | -1,222 | 351 |
| Beginning Cash Position | 105,187 | 71,425 | 648,607 | 71,791 | 66,417 |
| End Cash Position | 225,582 | 105,187 | 71,425 | 648,607 | 71,791 |
| Net Cash Flow | $120,395 | $33,762 | $-577,182 | $576,816 | $5,374 |
| Free Cash Flow | |||||
| Operating Cash Flow | -322,930 | -142,106 | -76,760 | -41,582 | -72,587 |
| Capital Expenditure | -657 | -139 | -128 | -624 | -306 |
| Free Cash Flow | -323,587 | -142,245 | -76,888 | -42,206 | -72,893 |